Strategies in Electrospun Polymer and Hybrid Scaffolds for Enhanced Cell Integration and Vascularization for Bone Tissue Engineering and Organoids
WIREs Nanomedicine and Nanobiotechnology · 2024
DOI: 10.1002/wnan.2022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Martyna Polak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Metals Engineering and Industrial Computer Science, AGH University of Krakow, Kraków, Poland. Hauptthemen laut MEDLINE: Tissue Engineering, Tissue Scaffolds, Organoids, Bone and Bones. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 262 Literaturangaben. Gefördert von: Narodowe Centrum Nauki, Excellence Initiative-Research University program for the AGH University of Krakow in Poland.
Abstract (Originalsprache)
Addressing the demand for bone substitutes, tissue engineering responds to the high prevalence of orthopedic surgeries worldwide and the limitations of conventional tissue reconstruction techniques. Materials, cells, and growth factors constitute the core elements in bone tissue engineering, influencing cellular behavior crucial for regenerative treatments. Scaffold design, including architectural features and porosity, significantly impacts cellular penetration, proliferation, differentiation, and vascularization. This review discusses the hierarchical structure of bone and the process of neovascularization in the context of biofabrication of scaffolds. We focus on the role of electrospinning and its modifications in scaffold fabrication to improve scaffold properties to enhance further tissue regeneration, for example, by boosting oxygen and nutrient delivery. We highlight how scaffold design impacts osteogenesis and the overall success of regenerative treatments by mimicking the extracellular matrix (ECM). Additionally, we explore the emerging field of bone organoids—self‐assembled, three‐dimensional (3D) structures derived from stem cells that replicate native bone tissue's architecture and functionality. While bone organoids hold immense potential for modeling bone diseases and facilitating regenerative treatments, their main limitation remains insufficient vascularization. Hence, we evaluate innovative strategies for pre‐vascularization and discuss the latest techniques for assessing and improving vascularization in both scaffolds and organoids presenting the most commonly used cell lines and biological models. Moreover, we analyze cutting‐edge techniques for assessing vascularization, evaluating their advantages and drawbacks to propose complex solutions. Finally, by integrating these approaches, we aim to advance the development of bioactive materials that promote successful bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Metals Engineering and Industrial Computer Science, AGH University of Krakow, Kraków, Poland.
ORCID-Profile: Martyna Polak, Joanna Ewa Karbowniczek, Urszula Stachewicz
Förderung
- Narodowe Centrum Nauki
- Excellence Initiative-Research University program for the AGH University of Krakow in Poland
Zitieren
APA
Polak, M., Karbowniczek, J. E., & Stachewicz, U. (2024). Strategies in Electrospun Polymer and Hybrid Scaffolds for Enhanced Cell Integration and Vascularization for Bone Tissue Engineering and Organoids. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.2022
Vancouver
Polak M, Karbowniczek JE, Stachewicz U. Strategies in Electrospun Polymer and Hybrid Scaffolds for Enhanced Cell Integration and Vascularization for Bone Tissue Engineering and Organoids. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.2022
BibTeX
@article{Polak2024,
author = {Polak, Martyna and Karbowniczek, Joanna Ewa and Stachewicz, Urszula},
title = {Strategies in Electrospun Polymer and Hybrid Scaffolds for Enhanced Cell Integration and Vascularization for Bone Tissue Engineering and Organoids},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
doi = {10.1002/wnan.2022}
}
EUVIMED